当前位置：
X-MOL 学术
›
JAMA Cardiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Somatic and Germline Variants and Coronary Heart Disease in a Chinese Population
JAMA Cardiology ( IF 24.0 ) Pub Date : 2024-01-10 , DOI: 10.1001/jamacardio.2023.5095 Kun Zhao 1 , Xuxiang Shen 1 , Hongwei Liu 1 , Zhennan Lin 1 , Jianxin Li 1 , Shufeng Chen 1 , Fangchao Liu 1 , Keyong Huang 1 , Jie Cao 1 , Xiaoqing Liu 2 , Chong Shen 3 , Ling Yu 4 , Yingxin Zhao 5 , Liancheng Zhao 1 , Ying Li 1 , Dongsheng Hu 6, 7 , Jiangfeng Huang 1 , Xiangfeng Lu 1 , Dongfeng Gu 1, 8
JAMA Cardiology ( IF 24.0 ) Pub Date : 2024-01-10 , DOI: 10.1001/jamacardio.2023.5095 Kun Zhao 1 , Xuxiang Shen 1 , Hongwei Liu 1 , Zhennan Lin 1 , Jianxin Li 1 , Shufeng Chen 1 , Fangchao Liu 1 , Keyong Huang 1 , Jie Cao 1 , Xiaoqing Liu 2 , Chong Shen 3 , Ling Yu 4 , Yingxin Zhao 5 , Liancheng Zhao 1 , Ying Li 1 , Dongsheng Hu 6, 7 , Jiangfeng Huang 1 , Xiangfeng Lu 1 , Dongfeng Gu 1, 8
Affiliation
ImportanceThe genetic basis of coronary heart disease (CHD) has expanded from a germline to somatic genome, including clonal hematopoiesis of indeterminate potential (CHIP). How CHIP confers CHD risk in East Asian individuals, especially those with small clones (variant allele fraction [VAF] 0.5%-2%) and different genetic backgrounds, was completely unknown.ObjectiveTo investigate the CHIP profile in a general Chinese cohort by deep sequencing and further explore the association between CHIP and incident CHD considering germline predisposition.Design, Setting, and ParticipantsThis cohort study used data from 3 prospective cohorts in the project Prediction for Atherosclerotic Cardiovascular Disease Risk in China. Participants without cardiovascular disease or cancer at baseline were enrolled in 2001 and 2008 and had a median follow-up of 12.17 years extending into 2021.ExposuresCHIP mutations were detected by targeted sequencing (mean depth, 916×). A predefined CHD polygenic risk score (PRS) comprising 531 variants was used to evaluate germline predisposition.Main Outcomes and MeasuresThe main outcome was first incident CHD.ResultsAmong 6181 participants, the median (IQR) age was 53.83 years (45.35-62.39 years); 3082 participants (49.9%) were female, and 3099 (50.1%) were male. A total of 1100 individuals (17.80%) harbored 1372 CHIP mutations at baseline. CHIP was independently associated with incident CHD (hazard ratio [HR], 1.42; 95% CI, 1.18-1.72; P = 2.82 × 10−4 ) and presented a risk gradient with increasing VAF (P = 3.98 × 10−3 for trend). Notably, individuals with small clones, nearly half of CHIP carriers, also demonstrated a higher CHD risk compared with non-CHIP carriers (HR, 1.33; 95% CI, 1.02-1.74; P = .03) and were 4 years younger than those with VAF of 2% or greater (median age, 58.52 vs 62.70 years). Heightened CHD risk was not observed among CHIP carriers with low PRS (HR, 1.02; 95% CI, 0.64-1.64; P = .92), while high PRS and CHIP jointly contributed a 2.23-fold increase in risk (95% CI, 1.51-3.29; P = 6.29 × 10−5 ) compared with non-CHIP carriers with low PRS. Interestingly, the diversity in CHIP-related CHD risk within each PRS group was substantially diminished when removing variants in the inflammatory pathway from the PRS.ConclusionsThis study revealed that elevated CHD risk attributed to CHIP was nonnegligible even for small clones. Inflammation genes involved in CHD could aggravate or abrogate CHIP-related CHD risk.
更新日期：2024-01-10
京公网安备 11010802027423号